Dr. Cohlmia is one of the very first physicians in Oklahoma and Arkansas to utilize a dissolvable stent treatment option for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK).

 

Until now, there were limited treatment options approved for blocked arteries below the knee in the U.S.

Abbott’s Esprit™ BTK System is implanted during a minimally invasive catheter-based procedure via a small incision in the leg. Once the blockage is open, the Esprit™ BTK System keeps the arteries open and delivers a drug called everolimus, to support vessel healing until it is strong enough to remain open on its own.